Other Species / Isoforms
  CRKL (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
R11
ARFDSSDRSAWYMGP
0 1
CRKL (human) ARFDSSDrSAWYMGP R11-m1
CRKL (mouse) ARFDSSDRSAWYMGP R11
CRKL (rat) ARFDSSDRSAWYMGP R11
S42-p
MFLVRDSsTCPGDyV
0 14
CRKL (human) MFLVRDSstCPGDyV S42-p
CRKL (mouse) MFLVRDSsTCPGDyV S42-p
CRKL (rat) MFLVRDSSTCPGDYV S42
T43
FLVRDSsTCPGDyVL
0 15
CRKL (human) FLVRDSstCPGDyVL T43-p
CRKL (mouse) FLVRDSsTCPGDyVL T43
CRKL (rat) FLVRDSSTCPGDYVL T43
Y48-p
SsTCPGDyVLSVSEN
0 12
CRKL (human) SstCPGDyVLSVSEN Y48-p
CRKL (mouse) SsTCPGDyVLSVSEN Y48-p
CRKL (rat) SSTCPGDYVLSVSEN Y48
Y92-p
LEFYKIHyLDTtTLI
Upstream
1 178
Treatment
  • tamoxifen
CRKL (human) LEFYKIHyLDtttLI Y92-p
CRKL (mouse) LEFYKIHyLDTtTLI Y92-p
CRKL (rat) LEFYKIHYLDTTTLI Y92
T95
YKIHyLDTtTLIEPA
0 2
CRKL (human) YKIHyLDtttLIEPA T95-p
CRKL (mouse) YKIHyLDTtTLIEPA T95
CRKL (rat) YKIHYLDTTTLIEPA T95
T96-p
KIHyLDTtTLIEPAP
0 4
CRKL (human) KIHyLDtttLIEPAP T96-p
CRKL (mouse) KIHyLDTtTLIEPAP T96-p
CRKL (rat) KIHYLDTTTLIEPAP T96
T97
IHyLDTtTLIEPAPR
0 1
CRKL (human) IHyLDtttLIEPAPR T97-p
CRKL (mouse) IHyLDTtTLIEPAPR T97
CRKL (rat) IHYLDTTTLIEPAPR T97
Y105-p
LIEPAPRyPsPPVGs
0 1
CRKL (human) LIEPAPRYPsPPMGs Y105
CRKL (mouse) LIEPAPRyPsPPVGs Y105-p
CRKL (rat) LIEPAPRYPNPPMGS Y105
S107-p
EPAPRyPsPPVGsVs
Upstream
0 16
Regulatory protein:
  • RIPK3 (mouse)
CRKL (human) EPAPRYPsPPMGsVs S107-p
CRKL (mouse) EPAPRyPsPPVGsVs S107-p
CRKL (rat) EPAPRYPNPPMGSVS N107
S112-p
yPsPPVGsVsAPNLP
0 4
CRKL (human) YPsPPMGsVsAPNLP S112-p
CRKL (mouse) yPsPPVGsVsAPNLP S112-p
CRKL (rat) YPNPPMGSVSAPNLS S112
S114-p
sPPVGsVsAPNLPTA
1 4
CRKL (human) sPPMGsVsAPNLPTA S114-p
CRKL (mouse) sPPVGsVsAPNLPTA S114-p
CRKL (rat) NPPMGSVSAPNLSTA S114
Y127-p
TAEENLEyVRtLyDF
0 35
CRKL (human) TAEDNLEyVRtLyDF Y127-p
CRKL (mouse) TAEENLEyVRtLyDF Y127-p
CRKL (rat) TAEENLEYVRTLyDF Y127
T130-p
ENLEyVRtLyDFPGN
0 6
CRKL (human) DNLEyVRtLyDFPGN T130-p
CRKL (mouse) ENLEyVRtLyDFPGN T130-p
CRKL (rat) ENLEYVRTLyDFPGN T130
Y132-p
LEyVRtLyDFPGNDA
0 134
CRKL (human) LEyVRtLyDFPGNDA Y132-p
CRKL (mouse) LEyVRtLyDFPGNDA Y132-p
CRKL (rat) LEYVRTLyDFPGNDA Y132-p
K145
DAEDLPFKKGELLVI
0 1
CRKL (human) DAEDLPFkKGEILVI K145-ub
CRKL (mouse) DAEDLPFKKGELLVI K145
CRKL (rat) DAEDLPFKKGELLVI K145
Y177
VGMIPVPYVEkLVRs
0 1
CRKL (human) VGMIPVPyVEkLVRs Y177-p
CRKL (mouse) VGMIPVPYVEkLVRs Y177
CRKL (rat) VGMIPVPYVEKLVRS Y177
K180
IPVPYVEKLVRssPH
0 1
CRKL (human) IPVPyVEkLVRssPH K180-ac
CRKL (mouse) IPVPYVEKLVRssPH K180
CRKL (rat) IPVPYVEKLVRSSPH K180
K180-ub
IPVPYVEkLVRssPH
0 5
CRKL (human) IPVPyVEkLVRssPH K180-ub
CRKL (mouse) IPVPYVEkLVRssPH K180-ub
CRKL (rat) IPVPYVEKLVRSSPH K180
S184-p
YVEkLVRssPHGKHG
0 5
CRKL (human) yVEkLVRssPHGKHG S184-p
CRKL (mouse) YVEkLVRssPHGKHG S184-p
CRKL (rat) YVEKLVRSSPHGKHG S184
S185-p
VEkLVRssPHGKHGN
0 3
CRKL (human) VEkLVRssPHGKHGN S185-p
CRKL (mouse) VEkLVRssPHGKHGN S185-p
CRKL (rat) VEKLVRSSPHGKHGN S185
S195-p
GKHGNRNsNsyGIPE
0 229
CRKL (human) GKHGNRNsNsyGIPE S195-p
CRKL (mouse) GKHGNRNsNsyGIPE S195-p
CRKL (rat) GKHGNRNSNSyGIPE S195
S197-p
HGNRNsNsyGIPEPA
0 100
CRKL (human) HGNRNsNsyGIPEPA S197-p
CRKL (mouse) HGNRNsNsyGIPEPA S197-p
CRKL (rat) HGNRNSNSyGIPEPA S197
Y198-p
GNRNsNsyGIPEPAH
0 285
CRKL (human) GNRNsNsyGIPEPAH Y198-p
CRKL (mouse) GNRNsNsyGIPEPAH Y198-p
CRKL (rat) GNRNSNSyGIPEPAH Y198-p
Y207-p
IPEPAHAyAQPQttt
Upstream
Downstream
16 1224
CRKL (human)
Y207-p
CRKL (mouse)
Y207-p
CRKL (rat)
Y207-p
Effects on Biological Processes:
  • apoptosis, inhibited
  • carcinogenesis, induced
  • cell growth, induced
  • signaling pathway regulation
Treatment
  • dasatinib
  • GNF-5
  • GNF2
  • imatinib
  • nilotinib
  • RAF265
  • SB590885
  • sorafenib
  • VEGF
view more >
CRKL (human) IPEPAHAyAQPQttt Y207-p
CRKL (mouse) IPEPAHAyAQPQttt Y207-p
CRKL (rat) IPEPAHAyAQPQTTT Y207-p
T212-p
HAyAQPQtttPLPtV
0 81
CRKL (human) HAyAQPQtttPLPAV T212-p
CRKL (mouse) HAyAQPQtttPLPtV T212-p
CRKL (rat) HAyAQPQTTTPLPTV T212
T213-p
AyAQPQtttPLPtVA
0 48
CRKL (human) AyAQPQtttPLPAVs T213-p
CRKL (mouse) AyAQPQtttPLPtVA T213-p
CRKL (rat) AyAQPQTTTPLPTVA T213
T214-p
yAQPQtttPLPtVAs
0 18
CRKL (human) yAQPQtttPLPAVsG T214-p
CRKL (mouse) yAQPQtttPLPtVAs T214-p
CRKL (rat) yAQPQTTTPLPTVAS T214
T218-p
QtttPLPtVAstPGA
0 1
CRKL (human) QtttPLPAVsGsPGA A218
CRKL (mouse) QtttPLPtVAstPGA T218-p
CRKL (rat) QTTTPLPTVASTPGA T218
A220
ttPLPtVAstPGAAI
0 24
CRKL (human) ttPLPAVsGsPGAAI S220-p
CRKL (mouse) ttPLPtVAstPGAAI A220
CRKL (rat) TTPLPTVASTPGAAI A220
S221-p
tPLPtVAstPGAAIN
0 1
CRKL (human) tPLPAVsGsPGAAIt G221
CRKL (mouse) tPLPtVAstPGAAIN S221-p
CRKL (rat) TPLPTVASTPGAAIN S221
T222-p
PLPtVAstPGAAINP
0 158
CRKL (human) PLPAVsGsPGAAItP S222-p
CRKL (mouse) PLPtVAstPGAAINP T222-p
CRKL (rat) PLPTVASTPGAAINP T222
N228
stPGAAINPLPSTQN
0 31
CRKL (human) GsPGAAItPLPstQN T228-p
CRKL (mouse) stPGAAINPLPSTQN N228
CRKL (rat) STPGAAINPLPSTQN N228
S232
AAINPLPSTQNGPVF
0 2
CRKL (human) AAItPLPstQNGPVF S232-p
CRKL (mouse) AAINPLPSTQNGPVF S232
CRKL (rat) AAINPLPSTQNGPVF S232
T233
AINPLPSTQNGPVFA
0 2
CRKL (human) AItPLPstQNGPVFA T233-p
CRKL (mouse) AINPLPSTQNGPVFA T233
CRKL (rat) AINPLPSTQNGPVFA T233
Y251-p
QKRVPCAyDKTALAL
Upstream
0 722
Regulatory protein:
  • Src iso1 (mouse)
CRKL (human) QKRVPCAyDktALAL Y251-p
CRKL (mouse) QKRVPCAyDKTALAL Y251-p
CRKL (rat) QKRVPCAyDKTALAL Y251-p
K253
RVPCAyDKTALALEV
0 4
CRKL (human) RVPCAyDktALALEV K253-ac
CRKL (mouse) RVPCAyDKTALALEV K253
CRKL (rat) RVPCAyDKTALALEV K253
K253
RVPCAyDKTALALEV
0 1
CRKL (human) RVPCAyDktALALEV K253-ub
CRKL (mouse) RVPCAyDKTALALEV K253
CRKL (rat) RVPCAyDKTALALEV K253
T254
VPCAyDKTALALEVG
0 4
CRKL (human) VPCAyDktALALEVG T254-p
CRKL (mouse) VPCAyDKTALALEVG T254
CRKL (rat) VPCAyDKTALALEVG T254
K283
EGEVNGRKGLFPFTH
0 1
CRKL (human) EGEVNGRkGLFPFTH K283-ub
CRKL (mouse) EGEVNGRKGLFPFTH K283
CRKL (rat) EGEVNGRKGLFPFTH K283
K292
LFPFTHVKIFDPQNP
0 3
CRKL (human) LFPFTHVkIFDPQNP K292-ub
CRKL (mouse) LFPFTHVKIFDPQNP K292
CRKL (rat) LFPFTHVKIFDPQNP K292